A detailed history of Russell Investments Group, Ltd. transactions in Insmed Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 86,759 shares of INSM stock, worth $6.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
86,759
Previous 55,164 57.27%
Holding current value
$6.18 Million
Previous $3.7 Million 71.39%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $1.96 Million - $2.5 Million
31,595 Added 57.27%
86,759 $6.33 Million
Q2 2024

Aug 08, 2024

BUY
$22.0 - $69.71 $727,386 - $2.3 Million
33,063 Added 149.6%
55,164 $3.7 Million
Q1 2024

May 08, 2024

BUY
$25.72 - $29.94 $564,888 - $657,572
21,963 Added 15915.22%
22,101 $599,000
Q4 2023

Feb 05, 2024

BUY
$23.42 - $31.74 $632 - $856
27 Added 24.32%
138 $4,000
Q3 2023

Nov 13, 2023

SELL
$19.86 - $26.93 $8,917 - $12,091
-449 Reduced 80.18%
111 $2,000
Q2 2023

Aug 10, 2023

BUY
$16.44 - $21.1 $904 - $1,160
55 Added 10.89%
560 $11,000
Q4 2022

Feb 08, 2023

SELL
$16.98 - $23.15 $1.8 Million - $2.45 Million
-105,841 Reduced 99.53%
505 $10,000
Q3 2022

Nov 04, 2022

BUY
$20.88 - $28.21 $2.21 Million - $2.98 Million
105,813 Added 19852.35%
106,346 $2.29 Million
Q2 2022

Jul 29, 2022

SELL
$17.07 - $25.71 $8,193 - $12,340
-480 Reduced 47.38%
533 $10,000
Q1 2022

May 05, 2022

SELL
$20.42 - $28.13 $804,895 - $1.11 Million
-39,417 Reduced 97.49%
1,013 $23,000
Q4 2021

Jan 21, 2022

SELL
$25.89 - $33.45 $93,954 - $121,390
-3,629 Reduced 8.24%
40,430 $1.1 Million
Q3 2021

Nov 08, 2021

SELL
$22.46 - $29.47 $149,516 - $196,181
-6,657 Reduced 13.13%
44,059 $1.21 Million
Q2 2021

Aug 04, 2021

SELL
$24.17 - $36.01 $252,093 - $375,584
-10,430 Reduced 17.06%
50,716 $1.44 Million
Q1 2021

May 10, 2021

SELL
$32.28 - $44.3 $1.87 Million - $2.57 Million
-57,997 Reduced 48.68%
61,146 $2.08 Million
Q4 2020

Feb 08, 2021

SELL
$31.45 - $40.54 $428,663 - $552,560
-13,630 Reduced 10.27%
119,143 $3.97 Million
Q3 2020

Nov 09, 2020

BUY
$26.0 - $34.5 $2.14 Million - $2.84 Million
82,316 Added 163.14%
132,773 $4.27 Million
Q2 2020

Aug 05, 2020

BUY
$14.11 - $29.42 $609,058 - $1.27 Million
43,165 Added 591.95%
50,457 $1.39 Million
Q1 2020

May 06, 2020

SELL
$13.63 - $33.98 $296,575 - $739,370
-21,759 Reduced 74.9%
7,292 $116,000
Q4 2019

Jan 29, 2020

BUY
$16.12 - $24.98 $468,302 - $725,693
29,051 New
29,051 $693,000
Q1 2019

May 13, 2019

SELL
$13.91 - $31.15 $85,101 - $190,575
-6,118 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$18.95 - $28.08 $390,862 - $579,178
-20,626 Reduced 77.12%
6,118 $125,000
Q2 2018

Aug 08, 2018

BUY
$20.0 - $29.72 $4,300 - $6,389
215 Added 0.81%
26,744 $633,000
Q1 2018

May 11, 2018

BUY
$21.69 - $32.99 $575,414 - $875,191
26,529 New
26,529 $598,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.